ArticleHeliyon2024

The necessity of thyroid-stimulating hormone suppression therapy for low-risk differentiated thyroid carcinoma following hemithyroidectomy: A systematic review and meta-analysis.

Xinyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.